
==== Front
J Clin MedJ Clin MedjcmJournal of Clinical Medicine2077-0383MDPI 10.3390/jcm6110106jcm-06-00106CorrectionTakamatsu, H. Comparison of Minimal Residual Disease Detection by Multiparameter Flow Cytometry, ASO-qPCR, Droplet Digital PCR, and Deep Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation. J. Clin. Med. 2017, 6, 91 Takamatsu Hiroyuki Hematology/Respiratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, 13-1 Takaramachi, Kanazawa, Ishikawa 920-8641, Japan; rgutierrez@example.org; Tel.: +81-76-265-227840-64-0353 11 2017 6 11 10840-64-0353 09 11 2017 © 2017 by the author.2017Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
==== Body
The author wishes to make the following correction to this paper [1]:

In figure 3, the name "LymphoSIGHTTM" should be replaced with "clonoSEQ®".
==== Refs
Reference
1. Takamatsu H.   Comparison of Minimal Residual Disease Detection by Multiparameter Flow Cytometry, ASO-qPCR, Droplet Digital PCR, and Deep Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation J. Clin. Med. 2017 6 91 10.3390/jcm6100091 28946710


{'source': 'PubMedDataset'}